logo

For the Inventor, By the Inventor

Carlsbad, CA, United States of America

Steven W Brostoff

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 130(Granted Patents)


Company Filing History:

goldMedal11 out of 33 
 
The Immune Response Corporation
 patents
silverMedal1 out of 20 
 
Avant Immunotherapeutics, Inc.
 patents

Years Active: 1997-2006

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7074407 - Method for increasing HDL cholesterol level (2006-07-11),
2. 6464978 - Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations (2002-10-15),
3. 6413516 - Peptides and methods against psoriasis (2002-07-02),
4. 6221352 - Method of preventing the proliferation of V&bgr;14 or V&bgr;17-Expressing T cells (2001-04-24),
5. 6207645 - Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations (2001-03-27),
6. 6159470 - Vaccination and methods against diseases resulting from pathogenic (2000-12-12),
7. 6090387 - Vaccination and methods against diseases resulting from pathogenic (2000-07-18),
8. 6007815 - Anti-idiotype vaccination against diseases resulting from pathogenic (1999-12-28),
9. 5985552 - Vaccination and methods against diseases resulting from pathogenic (1999-11-16),
10. 5861164 - Vaccination against diseases resulting from pathogenic responses by (1999-01-19),
11. 5837246 - Vaccination and methods against diseases resulting from pathogenic (1998-11-17),
12. 5612035 - Vaccination against diseases resulting from pathogenic responses by (1997-03-18),

Title: Innovations and Contributions of Steven W. Brostoff

Introduction

Steven W. Brostoff is a notable inventor based in Carlsbad, California, with a significant portfolio of 12 patents. His work primarily focuses on immunology and therapeutic methods aimed at improving health outcomes.

Latest Patents

Among his latest patents is a method for increasing HDL cholesterol levels. This invention provides a method for stimulating an immune response that inhibits the function of CETP, which can be induced by immunizing with CETP or its fragments. The peptides can be conjugated to carriers to enhance immunogenicity. Another significant patent involves vaccines and methods against multiple sclerosis, which aim to prevent or control specific T cell-mediated pathologies. This vaccine is composed of a T cell receptor or its fragments, administered in a way that induces an effective immunological response.

Career Highlights

Steven has worked with prominent companies in the field, including The Immune Response Corporation and Avant Immunotherapeutics, Inc. His contributions have been pivotal in advancing immunotherapeutic strategies.

Collaborations

He has collaborated with notable individuals such as Dennis J. Carlo and Mark D. Howell, further enhancing the impact of his work in the field of immunology.

Conclusion

Steven W. Brostoff's innovative contributions to immunology and therapeutic methods have made a significant impact on health science. His patents reflect a commitment to advancing medical knowledge and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…